Showing results (41-50 of 67) with videos related to
Sort By:
Pageof 7
EJNMMI Physics|February 11, 2020
Cellular dosimetry of [177Lu]Lu-DOTA-[Tyr3]octreotate radionuclide therapy: the impact of modeling assumptions on the correlation with in vitro cytotoxicityGiulia Tamborino, Marijke De Saint-Hubert, Lara Struelens, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2016
68Ga/177Lu-NeoBOMB1, a Novel Radiolabeled GRPR Antagonist for Theranostic Use in OncologySimone U Dalm, Ingrid L Bakker, Erik de Blois, et al.European Journal of Nuclear Medicine and Molecular Imaging|May 13, 2022
In vitro dose effect relationships of actinium-225- and lutetium-177-labeled PSMA-I&TEline A M Ruigrok, Giulia Tamborino, Erik de Blois, et al.Pharmaceuticals (Basel, Switzerland)|July 29, 2023
[212Pb]Pb-eSOMA-01: A Promising Radioligand for Targeted Alpha Therapy of Neuroendocrine TumorsDylan Chapeau, Sofia Koustoulidou, Maryana Handula, et al.European Journal of Nuclear Medicine and Molecular Imaging|August 11, 2022
Safety of [177Lu]Lu-NeoB treatment: a preclinical study characterizing absorbed dose and acute, early, and late organ toxicityEline A M Ruigrok, Marjolein Verhoeven, Mark W Konijnenberg, et al.European Journal of Nuclear Medicine and Molecular Imaging|May 11, 2016
Nephrotoxicity after PRRT with (177)Lu-DOTA-octreotateHendrik Bergsma, Mark W Konijnenberg, Wouter A van der Zwan, et al.Zeitschrift Fur Medizinische Physik|July 3, 2026
Limitations of Mono-Exponential Individual Fitting as a Reference Model for Single-Time-Point Dosimetry in [177Lu]Lu-PSMA-617 TherapyFulki Fiarka, Assyifa Rahman Hakim, Indra Budiansah, et al.Nuclear Medicine Communications|January 4, 2023
Kidney absorbed radiation doses for [ 177 Lu]Lu-PSMA-617 and [ 177 Lu]Lu-PSMA-I&T determined by 3D clinical dosimetryMaike J M Uijen, Bastiaan M Privé, Carla M L van Herpen, et al.European Journal of Nuclear Medicine and Molecular Imaging|December 1, 2022
Efficacy and safety of peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE in 15 patients with progressive treatment-refractory meningiomaNoémie S Minczeles, Eelke M Bos, Reinoud C de Leeuw, et al.European Journal of Nuclear Medicine and Molecular Imaging|July 13, 2022
Intraprocedural MRI-based dosimetry during transarterial radioembolization of liver tumours with holmium-166 microspheres (EMERITUS-1): a phase I trial towards adaptive, image-controlled treatment deliveryJoey Roosen, Lovisa E L Westlund Gotby, Mark J Arntz, et al.Pageof 7